Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Intangibles: 2010-2024

Historic Intangibles for OptimizeRx (OPRX) over the last 15 years, with FY2024 value amounting to $5.5 million.

  • OptimizeRx's Intangibles fell 1182.06% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 1182.06%. This contributed to the annual value of $5.5 million for FY2024, which is 9009.55% down from last year.
  • OptimizeRx's Intangibles amounted to $5.5 million in FY2024, which was down 9009.55% from $55.7 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Intangibles ranged from a high of $55.7 million in FY2023 and a low of $5.5 million during FY2024
  • Moreover, its 5-year median value for Intangibles was $17.5 million (2021), whereas its average is $23.5 million.
  • Per our database at Business Quant, OptimizeRx's Intangibles skyrocketed by 15520.48% in 2023 and then crashed by 9009.55% in 2024.
  • Annual analysis of 5 years shows OptimizeRx's Intangibles stood at $17.1 million in 2020, then increased by 2.25% to $17.5 million in 2021, then increased by 24.62% to $21.8 million in 2022, then soared by 155.2% to $55.7 million in 2023, then plummeted by 90.1% to $5.5 million in 2024.
  • Its last three reported values are $5.5 million in FY2024, $55.7 million for FY2023, and $21.8 million during FY2022.